SCHEMBL1084433

SCHEMBL1084433

Oc1ccccc1-c1nc(N2CCCC2c2ccncc2)c2ccc(Cl)cc2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMAD3 P84022 1/20 0.44
MAPT P10636 7/20 0.42
ALDH1A1 P00352 3/20 0.42
LMNA P02545 3/20 0.42
TSHR P16473 3/20 0.42
USP2 O75604 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
ALOX15 P16050 1/20 0.42
MAPK1 P28482 1/20 0.42
CYP2C19 P33261 1/20 0.42
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
CHEK2 O96017 1/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
HIF1A Q16665 3/20 0.40
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1084582 0.90 POLB (0.42) SMAD3MAPTALDH1A1LMNATSHR
SCHEMBL1084182 0.90 SMAD3 (0.43) SMAD3MAPTALDH1A1LMNATSHR
SCHEMBL1084410 0.89 CHEK2 (0.43) SMAD3MAPTALDH1A1LMNAMEN1
SCHEMBL1084543 0.89 SMAD3 (0.44) SMAD3MAPTALDH1A1LMNATSHR
SCHEMBL1084105 0.86 SMAD3 (0.43) SMAD3MAPTALDH1A1LMNATSHR
SCHEMBL1084171 0.86 SMAD3 (0.43) SMAD3MAPTALDH1A1LMNATSHR
SCHEMBL1083991 0.86 HIF1A (0.44) SMAD3MAPTLMNAMEN1KMT2A
SCHEMBL1084437 0.85 SMAD3 (0.43) SMAD3MAPTALDH1A1LMNATSHR
SCHEMBL1084502 0.84 PDE10A (0.43) SMAD3MAPTALDH1A1LMNATSHR
SCHEMBL1083914 0.83 SMAD3 (0.43) SMAD3MAPTALDH1A1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed